Teprotumumab by Horizon Therapeutics can really help with proptosis and diplopia in Graves’ disease and beyond.
batoclimab
Posted inAutoimmune Diseases, New Drugs, Rare/Orphan Diseases, Regulatory
Vyvgart: New Drug to Treat Myasthenia Gravis
Efgartigimod developed by Argenx is a strong competitor to Soliris.